Eli Lilly is a global pharmaceutical company with core franchises in diabetes, obesity, oncology, immunology, neuroscience and rare diseases. Market attention is centered on its GLP-1/GIP metabolic-drug portfolio, while pipeline progress, manufacturing capacity expansion and pricing/reimbursement policy remain key long-term variables.
Publicité
Publicité
RLLY
Rang #6922Eli Lilly and Co rStock
1,409.85
09 nov., 22:29 UTC
Eli Lilly and Co rStock (RLLY)
About
Informations et liens
Site Internet
Contrats
- arbitrum-one:0x3d1…782d5
- morph-l2:0xd4f…bad07
En savoir plus
Données provenant de
